VOLIOTIS DIMITRIS (SVP, Clinical Development) received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2021ACC: 0001725160-21-000037
Officer· SVP, Clinical Development
Since Apr 2020
+25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
New position
2/11/2021
0.00→6.25K
Total
Net shares
+6.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2021 | A · Award | +6.25K | — | — | New position | 0.00 | 6.25K |
| Total | +6.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
18.75K shares
Shares
+18.75K
Strike price
38.76
Held after
18.75K
Exercisable
—
2/11/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock18.75K shares | 2/11/2021 | A · Award | +18.75K | 38.76 | — | 18.75K |